ArticleThe American journal of case reports2025
Pancreatic Exocrine Insufficiency Years After Bariatric Surgery: Clinical Insights From 2 Cases.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Incidence of Secondary Pancreatic Exocrine Insufficiency after Metabolic Bariatric Surgery: a Systematic Review and Meta-Analysis.Obesity surgery · 2026Pooled it
- Unique causes of exocrine pancreatic insufficiency: When to consider pancreatic enzyme supplementation: A narrative review.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Bariatric surgery has been established as an effective intervention for significant and sustained weight loss in morbidly obese individuals. Roux-en-Y gastric bypass (RYGB) is a widely performed procedure that alters the gastrointestinal anatomy. A common symptom after bariatric surgery is diarrhea, which can be caused by several factors. A rare cause of diarrhea following RYGB is pancreatic exocrine insufficiency (PEI), which is often underrecognized in post-bariatric patients. While commonly associated with pancreatic diseases, PEI can also occur as a complication following bariatric surgeries such as RYGB. This report aims to raise awareness of delayed-onset PEI as a potential cause of chronic gastrointestinal symptoms in long-term RYGB patients and highlights the need for clinical vigilance to prevent unnecessary interventions and prolonged malnutrition. CASE REPORT We present 2 cases in which delayed-onset PEI developed several years after undergoing RYGB. Case 1 was a woman in her 40s who underwent RYGB. Seven years after surgery, she presented with unexplained severe diarrhea and progressive weight loss, from an initial BMI 28 kg/m² to 15.8 kg/m², in just a few months. Her fecal elastase level was 77 μg/g. She was successfully treated with pancreatic enzyme replacement treatment (PERT). Case 2 was a woman in her 50s with a history of RYGB 10 years prior, with an initial BMI of 46 kg/m2. She was evaluated for persistent diarrhea and left-sided abdominal pain, which had been ongoing for 6 months. Abdominal CT suggested adhesions around the jejuno-jejunostomy, and laparoscopic adhesiolysis was performed, but her symptoms persisted unchanged. Postoperatively, fecal elastase-1 testing confirmed the suspicion of PEI, and she was successfully treated with PERT. CONCLUSIONS Although PEI is a recognized complication of bariatric surgery, it is challenging to diagnose and treat due to limited awareness. This case report shows the importance of recognition and management of delayed-onset PEI following RYGB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.